Citable company snapshot

DGX company facts in plain English

Server-rendered

Quest Diagnostics's latest SEC-sourced 2026-03-31 period shows $2.90B in revenue and $252.00M in net income.

DGX company facts in plain English
MetricLatest periodLatest valuePrior valueYoY
xbrl:RevenueFromContractWithCustomerExcludingAssessedTaxMar 31, 2026$2.90B$2.81B+3.2%
xbrl:GrossProfitDec 31, 2020$1.27B$1.21B+5.2%
xbrl:OperatingIncomeLossMar 31, 2026$399.00M$386.00M+3.4%
xbrl:NetIncomeLossMar 31, 2026$252.00M$245.00M+2.9%
xbrl:NetCashProvidedByUsedInOperatingActivitiesMar 31, 2026$278.00M$465.00M-40.2%
Free Cash Flow (computed)Mar 31, 2026$164.00M$307.00M-46.6%

Source: SEC EDGAR XBRL; period Mar 31, 2026; filed Apr 22, 2026; accession 0001022079-26-000043.

Continue research

Follow same-sector companies and source explainers connected to the overview view.

Browse Health Care